Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Rush Street Interactive Inc (RSI) vs Tilray Brands Inc (TLRY) Price & Performance

Rush Street Interactive IncTrade
Tilray Brands IncTrade

Price performance (Past 24H)

Key statistics

Rush Street Interactive Inc vs Tilray Brands Inc — how do they compare? Rush Street Interactive Inc trades at $18.99 (market cap $2.35B), while Tilray Brands Inc trades at $3.54 (market cap $530.54M). The key difference: Rush Street Interactive Inc is far larger — about 4.4× Tilray Brands Inc's market cap, and Rush Street Interactive Inc is trading nearer its 52-week high, Tilray Brands Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Rush Street Interactive Inc for 13 Days and Tilray Brands Inc for 31 Days on average.

RSITLRY
Market Cap
$2.35B$530.54M
Volume
2,219,3749,099,075
Sector
Consumer CyclicalHealth
52-Week High
$34.52$21.00
52-Week Low
$15.89$3.57
Typical Hold Time
13 Days31 Days
Enterprise Value
$2.01B$684.46M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Rush Street Interactive Inc

RSI trades at $19.32, down 4.55% today, with bearish technical signals from moving averages but neutral oscillators. The company reported mixed quarterly earnings, beating in Q1 and Q2 2026 but missing in Q4 2025. Revenue grew to $1.13B in 2025 with a net income margin of 2.33%, though profitability faces pressure as margins are expected to compress slightly in 2026. Analyst sentiment remains strongly positive with a consensus price target of $34.88, representing significant upside potential from current levels.

The stock presents a compelling opportunity given the substantial analyst upside target, but faces near-term headwinds from technical weakness and margin compression. Key risks include competitive pressures in online gaming and execution challenges in maintaining growth momentum. Institutional buying activity, including BlackRock's $448M investment in August 2026, provides confidence in the long-term thesis despite current price volatility.

Tilray Brands Inc

Tilray Brands (TLRY) trades at $3.50, down 5.79% on the day and near its 52-week low. The stock shows bearish technical signals with negative moving averages and recent earnings misses across four consecutive quarters. Despite revenue growth to $821 million in 2025, the company reported a substantial net loss of $2.19 billion, driven by impairment charges and high operating costs. Analyst sentiment remains cautious with 65% hold ratings, though the consensus price target of $65.01 suggests significant potential upside from current levels.

The outlook remains challenging with persistent profitability issues and negative cash flow from operations. Investment opportunity exists if Tilray can achieve projected 2026 revenue growth to $915 million and reduce losses. Key risks include ongoing operational inefficiencies, competitive pressures in the cannabis market, and regulatory uncertainty. The stock's current valuation at 0.44 P/S and 0.33 P/B may attract value investors betting on a turnaround.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

RSI

No sentiment data available yet.

TLRY
54% Buy46% Sell
Avg holding period · 31 Days

Top news

Latest headlines on both assets

About Rush Street Interactive Inc

Rush Street Interactive, Inc. is a digital gaming and sports betting company operating in the regulated U.S. and international markets. The company owns and operates online casino (iGaming) and sports wagering platforms, including BetRivers and PlaySugarHouse brands. RSI focuses on providing a secure and high-quality online gaming experience, leveraging its proprietary technology platform and commitment to responsible gaming.

Read more on RSI →

About Tilray Brands Inc

Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.

Read more on TLRY →